| Dr Nichole Loser Nielsen, PHD | |
|
4462 E Bridleway Rd, Eagle Mountain, UT 84005-5874 | |
| (801) 472-2493 | |
| Not Available |
| Full Name | Dr Nichole Loser Nielsen |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 4462 E Bridleway Rd, Eagle Mountain, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609234996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 90948752501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nichole Loser Nielsen, PHD 4462 E Bridleway Rd, Eagle Mountain, UT 84005-5874 Ph: (801) 472-2493 | Dr Nichole Loser Nielsen, PHD 4462 E Bridleway Rd, Eagle Mountain, UT 84005-5874 Ph: (801) 472-2493 |
News Archive
Recovering unnecessarily lost patient information is now a viable reality. Lost to follow up rates in clinical research trials can range from 20- 60%. As a result, patients who drop from a clinical trial and 'go missing' can impart a major set-back in pharmaceutical research. Failure to contact patients and obtain final closure data, or bring them back into the clinical trial (if the protocol allows) results in study delays, increased patient recruitment costs, compromised study data, and in some cases an insufficient amount of information to prove the safety and efficacy of a drug.
Several news outlets are following the dilemmas that Democrats are facing in the health reform bills due to abortion.
The rapidly growing obesity epidemic and its complications are estimated to cost the American economy over $140 billion annually due to loss of productivity and medical complications. Attempts to solve this problem using weight loss programs have thus far failed due to low compliance.
Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.
A new global analysis of seafood found that fish populations throughout the world's oceans are contaminated with industrial and agricultural pollutants, collectively known as persistent organic pollutants (POPs). The study from researchers at Scripps Institution of Oceanography at UC San Diego also uncovered some good news¾concentrations of these pollutants have been consistently dropping over the last 30 years.
› Verified 8 days ago